ADMA (ADMA Biologics) Forward P/E Multiple
ADMA Biologics develops plasma-derived biologics with strict temperature control, leveraging diversified collection centers. The company is currently reducing its reliance on external laboratories through the localization of processes. The company's current forward P/E reflects the asset's valuation dynamics, where the value 14.80 represents the most recent figure. This defensive business remains stable during any market downturns, as life-saving therapies are not subject to seasonality.
Analytical breakdowns for ADMA Biologics
- current price and projected stock value:
- business market valuation indicators:
- book capitalization information:
- debt and liquidity details:
- company profitability and valuation multiples indicators:
ADMA - Company Profit|Expected Profit ADMA Biologics|ADMA - Price to Earnings Ratio|Forward P/E Multiple ADMA Bio|ADMA - PEG Multiple|Enterprise Value to EBITDA Ratio ADMA Biologics Inc|ADMA - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) ADMA Biologics|ADMA - Earnings per share for the last twelve months|Quarterly EPS earnings growth admabiologics.com|ADMA - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year ADMA Biologics
Summary company analytics:ADMA Biologics, Inc.
An investment audit of ADMA Biologics (ADMA) requires an analysis of the ratio between current market capitalization and projected net income for the next twelve months. This valuation methodology, presented via the company's forward P/E NTM on GURU.Markets, allows for a comparison between the value of a business with a strong reputation as a plasmapheresis innovator and its future efficiency, determining a fair balance between the quality premium and growth potential.
Competitors of ADMA Biologics (ADMA)
Projected Price to Earnings ARGX (argenx)|BNTX (BioNTech Inc.) - Future Price to Earnings Multiple|Forward P/E Multiple ABVX (abivax.com)|Market Cap to Projected Earnings Protagonist Corp (PTGX)|IMVT - Future Price to Earnings|kiniksa.com (KNSA) - Projected Price to Earnings|Grifols (GRFS) - Future Price to Earnings|Projected Price to Earnings Adaptive Biotech|Projected Price to Earnings CLDX|Forward P/E Multiple Aurinia Corp|Future Price to Earnings BioCryst (BCRX)|veratx.com - Price to Future Earnings Ratio|Forward P/E Multiple DNTH (Dianthus Therapeutics, Inc.)|Pharvaris NV (PHVS) - Projected Price to Earnings Ratio|AbCellera Bio - Forward P/E Multiple|TRML - Forward P/E Multiple|PGEN: Forward P/E Multiple|Price to Future Earnings Ratio PHAR|Future Price to Earnings Nektar Therapeutics Inc.|Projected Price to Earnings Upstream Bio, Inc. (UPB)|Forward P/E Multiple ZBIO|Forward P/E Multiple Immunome Bio (IMNM)|Gossamer Bio, Inc. - Projected Price to Earnings|Future Price to Earnings Multiple KALV|Septerna - Forward P/E Multiple|PVLA: Future Price to Earnings|SVRA: Forward P/E Multiple|RIGL - Market Cap to Projected Earnings|Future Price to Earnings AnaptysBio, Inc.|Projected Price to Earnings Ratio astriatx.com ATXS|Future Price to Earnings enGene (ENGN)|Future Price to Earnings RAPT (RAPT Therapeutics Inc.)|Future Price to Earnings Aerovate Therapeutics JBIO|Aclaris Therapeutics, Inc (ACRS) - Projected Price to Earnings Ratio|Kyverna Therapeutics - Forward P/E Multiple|Forward Price to Earnings Multiple tizianalifesciences.com (TLSA)|CABA: Forward P/E Multiple|VTYX - Market Cap to Projected Earnings|THTX (Theratechnologies Inc) - Forward P/E Multiple|Projected Price to Earnings Avalo Therapeutics Inc (AVTX)|Future Price to Earnings Eledon Pharmaceuticals (ELDN)|Market Cap to Projected Earnings agenusbio.com|Forward P/E Multiple CLYM (Climb Bio)|Forward P/E Multiple Zura Bio Ltd ZURA|aTyr - Forward P/E Multiple|ADAG (Adagene) - Price to Future Earnings Ratio|ikenaoncology.com (IMA) - Future Price to Earnings|Projected Price to Earnings Shattuck Labs|EQ (Equillium Inc) - Forward P/E Multiple|Forward P/E Multiple Connect Pharma|Future Price to Earnings Immunic, Inc. (IMUX)|ATRA: Price to Expected Earnings Ratio|Forward P/E Multiple IFRX (InflaRx)|Future Price to Earnings Multiple XFOR|Adicet - Forward P/E Multiple|CELU - Forward P/E Multiple|INmune Bio Corp (INMB) - Future Price to Earnings|Barinthus Biotherapeutics Corp - Future Price to Earnings Multiple|Future Price to Earnings Kezar Life Sciences|Projected Price to Earnings sabbiotherapeutics.com (SABS)|Forward P/E Multiple AKTX|Forward P/E Multiple enlivex.com (ENLV)|Q32 Bio - Projected Price to Earnings|Future Price to Earnings Multiple GOVX|Edesa Biotech, Inc. - Forward P/E Multiple|Market Cap to Projected Earnings ibioinc.com IBIO|carismatx.com (CARM) - Future Price to Earnings|Projected Price to Earnings XTL Biopharmaceuticals Ltd|Future Price to Earnings Bolt Biotherapeutics Inc.|Projected Price to Earnings HCW Biologics Inc (HCWB)|Projected Price to Earnings APVO (Aptevo Therapeutics)|Forward P/E Multiple AIM ImmunoTech, Inc. (AIM)|Future Price to Earnings Aditxt, Inc. ADTX|GRI: Price to Future Earnings Ratio|XORTX - Forward P/E Multiple|Projected Price to Earnings Ratio Vyome Therapeutics|REVB: Forward P/E Multiple|indaptusrx.com (INDP) - Forward P/E Multiple|SCNI (Scinai Immunotherapeutics Ltd.) - Forward P/E Multiple|Price to Future Earnings Ratio CALI (CalciMedica Corp)|Future Price to Earnings Affimed (AFMD)|Projected Price to Earnings allakos.com ALLK|Forward P/E Multiple HOOK (HOOKIPA Pharma)|Forward P/E Multiple IGM Biosciences Inc. IGMS|ITOS: Projected Price to Earnings|Future Price to Earnings Multiple OCEA (Ocean Biomedical Inc)|TCBP: Forward P/E Multiple|THRD (Third Harmonic Bio Inc) - Future Price to Earnings
